MedPath

The Effect of Allogeneic Human Adipose Derived Stem Cell Component Extract on Androgenic Alopecia

Not Applicable
Completed
Conditions
Androgenic Alopecia
Interventions
Other: stem cell component extract
Registration Number
NCT02594046
Lead Sponsor
Pusan National University Hospital
Brief Summary

This randomized, placebo-controlled, double-blind study evaluates the efficacy and tolerability of the allogeneic human adipose derived stem cell component extract on androgenic alopecia in relatively healthy adults. A total of 38 subjects received 1.2 g of allogeneic human adipose derived stem cell component extract per month or a placebo for 16 weeks.

Detailed Description

This randomized, placebo-controlled, double-blind study evaluates the efficacy and tolerability of the allogeneic human adipose derived stem cell component extract on androgenic alopecia in relatively healthy adults. A total of 38 subjects received 1.2 g of allogeneic human adipose derived stem cell component extract per month or a placebo for 16 weeks. Hair count and thickness will be primary outcomes.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
38
Inclusion Criteria
  • androgenic alopecia basic and specific(BASP) classification: M2, C2, U1, V1, or F1 or higher
Read More
Exclusion Criteria
  • patient of scalp disease
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
stem cell groupstem cell component extractstem cell group who apply 1.2 g of allogeneic human adipose derived stem cell component extract on their scalp for 16 weeks
placebo groupstem cell component extractplacebo group who apply a placebo on their scalp for 16 weeks
Primary Outcome Measures
NameTimeMethod
change of total hair counts by phototrichogram16 weeks
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath